Glycyrrhetinic acid derivatives for treating hyperkalemia
US11768319B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2018 |
| Grant date | Sep 26, 2023 |
| Priority date | — |
| Expiry date | Jun 27, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG02F1/133526
- WIPO fieldOptics
- WIPO sectorInstruments
Abstract
The present invention provides a compound of formula (I) or a salt thereof: (I) wherein X, L, V, R1, R2, R3 and R4, are as defined herein. These compounds are inhibitors of 11-hydroxysteroid dehydrogenase type 2 (11-HSD-2) and are used to treat hyperkalemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.